Whitehawk Therapeutics, Inc.
WHWK- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422142
No open-market purchases or sales by Whitehawk Therapeutics, Inc. insiders were filed in the last 90 days; 77 institutions reported holding it in 13F filings for Q2 2026, worth $198.0M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Whitehawk Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +13 vs. Q3 2021
- Shares held
- 12.2M
- +1.09M (+9.8%) vs. Q3 2021
- Total value
- $294.2M
- −$29.9M (−9.2%) vs. Q3 2021
- New holders
- 19
- 11 more added
- Sold out
- 6
- 5 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting WHWK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 77 | $198.0M |
| Q1 2026 | 62 | $118.2M |
| Q4 2025 | 48 | $79.2M |
| Q3 2025 | 41 | $54.3M |
| Q2 2025 | 39 | $54.6M |
| Q1 2025 | 50 | $56.2M |
| Q4 2024 | 53 | $47.2M |
| Q3 2024 | 52 | $24.7M |
| Q2 2024 | 65 | $16.7M |
| Q1 2024 | 60 | $30.9M |
| Q4 2023 | 65 | $25.8M |
| Q3 2023 | 73 | $75.3M |
| Q2 2023 | 67 | $100.8M |
| Q1 2023 | 70 | $106.6M |
| Q4 2022 | 76 | $192.2M |
| Q3 2022 | 68 | $212.1M |
| Q2 2022 | 68 | $159.3M |
| Q1 2022 | 55 | $213.8M |
| Q4 2021 | 46 | $294.2M |
| Q3 2021 | 33 | $324.1M |
| Q2 2021 | 43 | $51.0M |
| Q1 2021 | 42 | $34.3M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Whitehawk Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Truepoint, Inc. | 10,219 | $0 | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 15 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 100 | $2.00K | 0.00% | +100 | New |
| Investmark Advisory Group LLC | 100 | $2.00K | 0.00% | +100 | New |
| Tower Research Capital LLC (TRC) | 170 | $4.00K | 0.00% | +130+325.0% | Added |
| TD Waterhouse Canada Inc. | 232 | $5.68K | 0.00% | +232 | New |
| Advisor Group Holdings, Inc. | 259 | $6.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 794 | $19.0K | 0.00% | +714+892.5% | Added |
| Morgan Stanley | 2,691 | $65.0K | 0.00% | +2,600+2,857.1% | Added |
| US Bancorp | 3,333 | $80.0K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 6,408 | $155.0K | 0.01% | 00.0% | Unchanged |
| Ascent Wealth Partners, LLC | 10,000 | $241.0K | 0.04% | +10,000 | New |
| Cubist Systematic Strategies, LLC | 10,975 | $265.0K | 0.00% | +10,975 | New |
| Bank of New York Mellon Corp | 11,306 | $273.0K | 0.00% | +11,306 | New |
| Schonfeld Strategic Advisors LLC | 15,800 | $381.0K | 0.00% | +15,800 | New |
| 683 Capital Management, LLC | 18,025 | $435.0K | 0.02% | +18,025 | New |
| Susquehanna International Group, LLP | 21,957 | $530.0K | 0.00% | +21,957 | New |
| UBS Group AG | 24,094 | $581.0K | 0.00% | +23,854+9,939.2% | Added |
| Alps Advisors Inc | 24,174 | $584.0K | 0.01% | +24,174 | New |
| Boothbay Fund Management, LLC | 24,952 | $603.0K | 0.02% | +24,952 | New |
| ABG Innovation Capital Partners III GP Ltd | 26,666 | $644.0K | 37.25% | 00.0% | Unchanged |
| Rafferty Asset Management, LLC | 27,967 | $675.0K | 0.00% | +27,967 | New |
| Marshall Wace, LLP | 29,173 | $704.0K | 0.00% | +29,173 | New |
| TD Asset Management Inc | 34,783 | $840.0K | 0.00% | +34,783 | New |
| Bank of America Corp | 35,903 | $867.0K | 0.00% | +35,903 | New |
| Citigroup Inc | 36,166 | $873.0K | 0.00% | +35,518+5,481.2% | Added |
| Northern Trust Corp | 36,808 | $889.0K | 0.00% | +36,808 | New |
| HighVista Strategies LLC | 40,549 | $979.0K | 0.78% | +40,549 | New |
| OrbiMed Advisors LLC | 127,600 | $3.08M | 0.04% | −218,662−63.1% | Reduced |
| Renaissance Technologies LLC | 128,522 | $3.10M | 0.00% | −37,133−22.4% | Reduced |
| Ikarian Capital, LLC | 196,408 | $4.74M | 1.36% | +185,000+1,621.7% | Added |
| Geode Capital Management, LLC | 197,073 | $4.76M | 0.00% | +168,970+601.3% | Added |
| Ghost Tree Capital, LLC | 200,000 | $4.83M | 1.85% | +200,000 | New |
| Citadel Advisors LLC | 230,529 | $5.57M | 0.01% | +131,336+132.4% | Added |
| BlackRock Inc. | 309,554 | $7.47M | 0.00% | +293,304+1,804.9% | Added |
| State Street Corp | 311,400 | $7.52M | 0.00% | +311,400 | New |
| Satter Management Co., L.P. | 374,785 | $9.05M | 9.21% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 508,892 | $12.3M | 0.00% | +43,293+9.3% | Added |
| Rock Springs Capital Management LP | 538,835 | $13.0M | 0.30% | −225,866−29.5% | Reduced |
| Vanguard Group Inc | 761,473 | $18.4M | 0.00% | +643,196+543.8% | Added |
| RTW Investments, LP | 764,701 | $18.5M | 0.27% | 00.0% | Unchanged |
| BVF Inc | 899,392 | $21.7M | 0.79% | −247,660−21.6% | Reduced |
| Vivo Capital, LLC | 1,303,390 | $31.5M | 1.90% | −123,823−8.7% | Reduced |
| Acuta Capital Partners, LLC | 1,529,402 | $36.9M | 15.53% | 00.0% | Unchanged |
| VR Adviser, LLC | 1,529,402 | $36.9M | 5.05% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 1,829,402 | $44.2M | 0.75% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −347,668−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −45,020−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −28,343−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −20,343−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |